Dolby Laboratories
DLB

Dolby Laboratories (DLB) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
RosenblattMaintainedBuy$85.00Aug 28, 2026
RosenblattMaintainedBuy$85.00Jul 31, 2026
Barrington ResearchMaintainedOutperform$90.00Jun 15, 2026
RosenblattMaintainedBuy$85.00Jun 11, 2026
Barrington ResearchMaintainedOutperform$90.00Apr 27, 2026
Barrington ResearchMaintainedOutperform$90.00Jan 30, 2026
RosenblattMaintainedBuy$85.00Jan 30, 2026
Barrington ResearchMaintainedOutperform$90.00 from $95.00Jan 26, 2026
RosenblattMaintainedBuy$85.00Jan 22, 2026
Barrington ResearchMaintainedOutperform$95.00 from $100.00Nov 19, 2025
RosenblattMaintainedBuy$85.00 from $95.00Nov 19, 2025
Barrington ResearchMaintainedOutperform$100.00Sep 12, 2025
BairdInitiated CoverageNeutral$74.00Sep 5, 2025
Tigress FinancialMaintainedBuy$114.00 from $112.00Aug 15, 2025
RosenblattMaintainedBuy$95.00Aug 1, 2025
RosenblattMaintainedBuy$95.00Jun 13, 2025
Tigress FinancialMaintainedBuy$112.00 from $116.00May 15, 2025
Barrington ResearchMaintainedOutperform$100.00May 2, 2025
RosenblattMaintainedBuy$95.00 from $100.00May 2, 2025
Barrington ResearchMaintainedOutperform$100.00Feb 13, 2025

Frequently asked questions

  • What is the latest analyst rating on DLB?

    On Aug 28, 2026, Rosenblatt maintained Dolby Laboratories at Buy with a price target of $85.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.